Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 481 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
481
Total Funding
$1.4B
Avg Funding
$56.5M
Cities
21

Export 481 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Antonio, United States
$1.5M
raised

Scorpius Biomanufacturing is a CDMO specializing in mammalian, microbial, and cell therapies for biologics development and manufacturing.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lublin, Poland
$3.3M
raised

SDS Optic specializes in pre-assembling of hermetic and standard photoelectronics components.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$6.0M
raised

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Charlestown, United States
$240.0M
raised

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$7.1M
raised

Defence Therapeutics is a scientific pioneer on a journey to uncover enhanced treatment solutions for future generations.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
London, United Kingdom
$34.0M
raised

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$1.1M
raised

GenFlow Biosciences is a biotech company that develops gene therapies for slow or reverse aging in humans and animals.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$366.9M
raised

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$1.8M
raised

Mountain Valley MD Holdings is in the final stages of proving up a low-cost, low-risk exploration project.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Rome, Italy
$2.3M
raised

Cube Labs is the first systematic venture builder in the healthcare technology space in Italy.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Encinitas, United States
$2.0M
raised

Dermata Therapeutics is a biotechnology firm that focuses on advancements in the treatment of serious diseases treated by dermatologists.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$432K
raised

Arch Biopartners acquires and develops products and technology for sale to pharmaceutical and industrial companies.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$10.0M
raised

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Kelowna, Canada
$25.8M
raised

The Valens Company is a biotechnology company focused on extraction and the commercialization of cannabinoid-based consumer products.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

St Louis, United States
$85.0M
raised

Benson Hill is a provider of crop design platform to develop healthier and more sustainable food and ingredients.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Carlsbad, United States
$3.0M
raised

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wroclaw, Poland
$17.7M
raised

Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$75.0M
raised

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

La Jolla, United States
$11.0M
raised

Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boulder, United States
$150.0M
raised

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Greenwood Village, United States
$2.8M
raised

Applied UV focuses on the development and acquisition of technologies on infection prevention in healthcare, hospitality, and residential.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bedford, United States
$125.0M
raised

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bogotá, Colombia
$600K
raised

Khiron is a medical cannabis company that promotes science, medicine, technology, innovation, and efficiency.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$240.0M
raised

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lund, Sweden
$967K
raised

Hamlet BioPharma is a pharmaceutical company with strong links to research.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 251 to 275 of 481 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 481 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked